KDM2A/7A-IN-1 is primarily used in research to study the role of histone demethylases in cellular processes. It acts as an inhibitor of KDM2A and KDM7A enzymes, which are involved in the regulation of gene expression through histone modification. By inhibiting these enzymes, researchers can investigate their impact on epigenetic mechanisms, potentially uncovering pathways related to cancer development and progression. This compound is valuable in preclinical studies aimed at understanding the therapeutic potential of targeting histone demethylases in diseases such as cancer, where abnormal gene expression plays a critical role. Additionally, it helps in exploring the broader implications of epigenetic regulation in cellular differentiation and disease states.